Inventor · disambiguated record
Michael Eamon Peter O'Dwyer
Also filed as: O'DWYER MICHAEL · O'DWYER MICHAEL EAMON PETER
5 granted patents·12 pending applications·32 citations·filing 1993–2022
77Inventor score
Top patents by PatentIndex Score
17 records- 0185US10799536B2Method of treating multiple myeloma using natural killer cells expressing a chimeric antigen receptor for CD38ONKIMMUNE LTD·Filed 2017·Granted Oct 13, 2020·5 cites·12 claims
- 0281US10960064B2Modified natural killer cells and natural killer cell lines having increased cytotoxicityONK THERAPEUTICS LTD·Filed 2018·Granted Mar 30, 2021·4 cites·16 claims
- 0374US10034925B2Modified natural killer cells and natural killer cell lines having increased cytotoxicityONKIMMUNE LTD·Filed 2017·Granted Jul 31, 2018·3 cites·12 claims
- 0459US10906951B2Modified natural killer cells and natural killer cell lines having increased cytotoxicityONK THERAPEUTICS LTD·Filed 2018·Granted Feb 2, 2021·0 cites·9 claims
- 0557US2021138051A1Modified Natural Killer Cells and Natural Killer Cell Lines Having Increased CytotoxicityONK THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 0656US2013040299A1Method for detecting or monitoring sepsis by analysing cytokine mrna expression levelsTRINITY COLLEGE DUBLIN·Filed 2012·Application pending·0 cites
- 0756US2009297474A1Method for Detecting or Monitoring Sepsis by Analysing Cytokine mRNA Expression LevelsKELLEHER DERMOT·Filed 2006·Application pending·0 cites
- 0855US2021230241A1Modified natural killer cells and natural killer cell lines having increased cytotoxicityONK THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 0955US2023019381A1Nk cell-based therapyONK THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1049US5286403AConcentrated cleaning compositionsDWYER MICHAEL O·Filed 1993·Granted Feb 15, 1994·20 cites·9 claims
- 1147US2022143089A1Modified immune effector cells with increased resistance to cell deathONK THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 1245US2023210903A1Hypoxia-resistant natural killer cellsONK THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 1345US2019321402A1Nk cells for use with anitbodies in cancer therapyONKIMMUNE LTD·Filed 2019·Application pending·0 cites
- 1442US2021186999A1Method for treatment of cancerNAT UNIV IRELAND GALWAY·Filed 2018·Application pending·0 cites
- 1540US2020392458A1Modified natural killer cells and natural killer cell lines targetting tumour cellsONK THERAPEUTICS LTD·Filed 2018·Application pending·0 cites
- 1640US2018344768A1Nk cell-based therapyONKIMMUNE LTD·Filed 2017·Application pending·0 cites
- 1739US2018117150A1Combination Therapies for CD38-Positive Hematological Malignances with ANTI-CD38 Antibodies and CyclophosphamideJANSSEN BIOTECH INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Eamon Peter O'Dwyer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →